Prevalence of Vaccination Rates in Systolic Heart Failure: A Prospective Study of 549 Patients by Age, Race, Ethnicity, and Sex in a Heart Failure Disease Management Program

Kathy Hebert, George Marzouka, Lee Arcement, Elyse Julian, Frank Cortazar, Andre Dias, Leonardo Tamariz

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Healthy People 2010 aims at immunizing 60% of high-risk adults annually against influenza and once against pneumococcal disease. The aim of this study was to evaluate the use of a standardized approach to improve vaccination rates in patients with heart failure (HF); to determine whether disparities exist based on age, race, ethnicity, or sex at baseline and follow-up; and to evaluate the impact of clinical variables on the odds of being vaccinated. A prospective study of 549 indigent patients enrolled in a systolic HF disease management program (HFDMP) began enrollment from August 2007 to January 2009 at Jackson Memorial Hospital. Patients were interviewed at their initial visit for immunization status; those without vaccinations were offered the vaccines. Prevalence of vaccination (POV) for influenza and pneumococcal disease was obtained at baseline and at follow-up. The odds ratio for being vaccinated was calculated using logistic regression. The study population comprised mostly Hispanic (56%), black (37%), and male (70%) patients, with a mean age of 56±12 years and a mean ejection fraction of 25%±10%. The initial POV for both was 22% at baseline. At follow-up, POV improved to 60.5%. Of those not vaccinated at baseline, 17.5% refused vaccination. Odds ratios at baseline for age, race/ethnicity, and sex were 0.99 (P=99), 0.63 (P=08), and 0.62 (P=14), respectively. These did not change significantly at follow-up. Prevalence of vaccination in our cohort was low. Enrollment into the HFDMP improved immunization prevalence without creating age, race, ethnicity, or sex disparities. Congest Heart Fail.

Original languageEnglish
Pages (from-to)278-283
Number of pages6
JournalCongestive Heart Failure
Volume16
Issue number6
DOIs
StatePublished - Nov 1 2010

Fingerprint

Systolic Heart Failure
Disease Management
Heart Diseases
Vaccination
Heart Failure
Prospective Studies
Human Influenza
Odds Ratio
Healthy People Programs
Conjugated (USP) Estrogens
Immunization Programs
Poverty
Hispanic Americans
Immunization
Vaccines
Logistic Models

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Emergency Medicine
  • Emergency

Cite this

Prevalence of Vaccination Rates in Systolic Heart Failure : A Prospective Study of 549 Patients by Age, Race, Ethnicity, and Sex in a Heart Failure Disease Management Program. / Hebert, Kathy; Marzouka, George; Arcement, Lee; Julian, Elyse; Cortazar, Frank; Dias, Andre; Tamariz, Leonardo.

In: Congestive Heart Failure, Vol. 16, No. 6, 01.11.2010, p. 278-283.

Research output: Contribution to journalArticle

@article{d03f64404e094faab32e10317b5f27c3,
title = "Prevalence of Vaccination Rates in Systolic Heart Failure: A Prospective Study of 549 Patients by Age, Race, Ethnicity, and Sex in a Heart Failure Disease Management Program",
abstract = "Healthy People 2010 aims at immunizing 60{\%} of high-risk adults annually against influenza and once against pneumococcal disease. The aim of this study was to evaluate the use of a standardized approach to improve vaccination rates in patients with heart failure (HF); to determine whether disparities exist based on age, race, ethnicity, or sex at baseline and follow-up; and to evaluate the impact of clinical variables on the odds of being vaccinated. A prospective study of 549 indigent patients enrolled in a systolic HF disease management program (HFDMP) began enrollment from August 2007 to January 2009 at Jackson Memorial Hospital. Patients were interviewed at their initial visit for immunization status; those without vaccinations were offered the vaccines. Prevalence of vaccination (POV) for influenza and pneumococcal disease was obtained at baseline and at follow-up. The odds ratio for being vaccinated was calculated using logistic regression. The study population comprised mostly Hispanic (56{\%}), black (37{\%}), and male (70{\%}) patients, with a mean age of 56±12 years and a mean ejection fraction of 25{\%}±10{\%}. The initial POV for both was 22{\%} at baseline. At follow-up, POV improved to 60.5{\%}. Of those not vaccinated at baseline, 17.5{\%} refused vaccination. Odds ratios at baseline for age, race/ethnicity, and sex were 0.99 (P=99), 0.63 (P=08), and 0.62 (P=14), respectively. These did not change significantly at follow-up. Prevalence of vaccination in our cohort was low. Enrollment into the HFDMP improved immunization prevalence without creating age, race, ethnicity, or sex disparities. Congest Heart Fail.",
author = "Kathy Hebert and George Marzouka and Lee Arcement and Elyse Julian and Frank Cortazar and Andre Dias and Leonardo Tamariz",
year = "2010",
month = "11",
day = "1",
doi = "10.1111/j.1751-7133.2010.00190.x",
language = "English",
volume = "16",
pages = "278--283",
journal = "Congestive Heart Failure",
issn = "1527-5299",
publisher = "Wiley-Blackwell",
number = "6",

}

TY - JOUR

T1 - Prevalence of Vaccination Rates in Systolic Heart Failure

T2 - A Prospective Study of 549 Patients by Age, Race, Ethnicity, and Sex in a Heart Failure Disease Management Program

AU - Hebert, Kathy

AU - Marzouka, George

AU - Arcement, Lee

AU - Julian, Elyse

AU - Cortazar, Frank

AU - Dias, Andre

AU - Tamariz, Leonardo

PY - 2010/11/1

Y1 - 2010/11/1

N2 - Healthy People 2010 aims at immunizing 60% of high-risk adults annually against influenza and once against pneumococcal disease. The aim of this study was to evaluate the use of a standardized approach to improve vaccination rates in patients with heart failure (HF); to determine whether disparities exist based on age, race, ethnicity, or sex at baseline and follow-up; and to evaluate the impact of clinical variables on the odds of being vaccinated. A prospective study of 549 indigent patients enrolled in a systolic HF disease management program (HFDMP) began enrollment from August 2007 to January 2009 at Jackson Memorial Hospital. Patients were interviewed at their initial visit for immunization status; those without vaccinations were offered the vaccines. Prevalence of vaccination (POV) for influenza and pneumococcal disease was obtained at baseline and at follow-up. The odds ratio for being vaccinated was calculated using logistic regression. The study population comprised mostly Hispanic (56%), black (37%), and male (70%) patients, with a mean age of 56±12 years and a mean ejection fraction of 25%±10%. The initial POV for both was 22% at baseline. At follow-up, POV improved to 60.5%. Of those not vaccinated at baseline, 17.5% refused vaccination. Odds ratios at baseline for age, race/ethnicity, and sex were 0.99 (P=99), 0.63 (P=08), and 0.62 (P=14), respectively. These did not change significantly at follow-up. Prevalence of vaccination in our cohort was low. Enrollment into the HFDMP improved immunization prevalence without creating age, race, ethnicity, or sex disparities. Congest Heart Fail.

AB - Healthy People 2010 aims at immunizing 60% of high-risk adults annually against influenza and once against pneumococcal disease. The aim of this study was to evaluate the use of a standardized approach to improve vaccination rates in patients with heart failure (HF); to determine whether disparities exist based on age, race, ethnicity, or sex at baseline and follow-up; and to evaluate the impact of clinical variables on the odds of being vaccinated. A prospective study of 549 indigent patients enrolled in a systolic HF disease management program (HFDMP) began enrollment from August 2007 to January 2009 at Jackson Memorial Hospital. Patients were interviewed at their initial visit for immunization status; those without vaccinations were offered the vaccines. Prevalence of vaccination (POV) for influenza and pneumococcal disease was obtained at baseline and at follow-up. The odds ratio for being vaccinated was calculated using logistic regression. The study population comprised mostly Hispanic (56%), black (37%), and male (70%) patients, with a mean age of 56±12 years and a mean ejection fraction of 25%±10%. The initial POV for both was 22% at baseline. At follow-up, POV improved to 60.5%. Of those not vaccinated at baseline, 17.5% refused vaccination. Odds ratios at baseline for age, race/ethnicity, and sex were 0.99 (P=99), 0.63 (P=08), and 0.62 (P=14), respectively. These did not change significantly at follow-up. Prevalence of vaccination in our cohort was low. Enrollment into the HFDMP improved immunization prevalence without creating age, race, ethnicity, or sex disparities. Congest Heart Fail.

UR - http://www.scopus.com/inward/record.url?scp=78649466235&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78649466235&partnerID=8YFLogxK

U2 - 10.1111/j.1751-7133.2010.00190.x

DO - 10.1111/j.1751-7133.2010.00190.x

M3 - Article

C2 - 21091613

AN - SCOPUS:78649466235

VL - 16

SP - 278

EP - 283

JO - Congestive Heart Failure

JF - Congestive Heart Failure

SN - 1527-5299

IS - 6

ER -